For musculoskeletal indications, the guideline is progressive load reintroduction starting no earlier than 6 to 8 weeks, with full training not before 3 months for significant tendon injuries regardless of how good the patient feels
References: Yanagisawa A
GLP-1s are designed to work best when the dose is increased gradually, giving your body time to adapt to changes in appetite and digestion
This analysis revealed no statistically significant increase in pancreatitis risk compared to placebo across all Mounjaro doses: 5 mg dose: Risk Ratio 2.04, 95% CI [0.2715.69], p = 0.49 10 mg dose: Risk Ratio 0.63, 95% CI [0.085.12], p = 0.67 15 mg dose: Risk Ratio 1.26, 95% CI [0.364.98], p = 0.72 In simpler terms, this means that no dose of Mounjaro showed a clear increase in pancreatitis risk compared to taking a placebo
This ensures all patients have flexible and accessible options
In a study in adults with HIV/AIDS, tesamorelin at a dose of 2mg/daily significantly reduced muscle wasting
